Evidence-Based Medicine Guidelines
Purine antagonists compared to alkylating agents for chronic lymphocytic leukaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Purine Antagonists Compared to Alkylating Agents for Chronic Lymphocytic Leukaemia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450148/all/Purine_antagonists_compared_to_alkylating_agents_for_chronic_lymphocytic_leukaemia.
Purine antagonists compared to alkylating agents for chronic lymphocytic leukaemia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450148/all/Purine_antagonists_compared_to_alkylating_agents_for_chronic_lymphocytic_leukaemia. Accessed December 3, 2023.
Purine antagonists compared to alkylating agents for chronic lymphocytic leukaemia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450148/all/Purine_antagonists_compared_to_alkylating_agents_for_chronic_lymphocytic_leukaemia
Purine Antagonists Compared to Alkylating Agents for Chronic Lymphocytic Leukaemia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450148/all/Purine_antagonists_compared_to_alkylating_agents_for_chronic_lymphocytic_leukaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Purine antagonists compared to alkylating agents for chronic lymphocytic leukaemia
ID - 450148
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450148/all/Purine_antagonists_compared_to_alkylating_agents_for_chronic_lymphocytic_leukaemia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
